AHA 2013: Top Trial Hits and Misses from Dr Valentin Fuster and Panel
 
 
This feature requires the newest version of Flash. You can download it here.
November 20, 2013
Recorded November 19, 2013

This year's Cardiology Show tackles ENGAGE-AF, STREAM, COAG, CTSN-MR, TOPCAT, and EU-PACT, but prevention with a personal touch is the key. That's the take-away from AHA 2013 according to Dr Valentin Fuster and panelists Drs Jessica Mega, Magnus Ohman, Bob Harrington, Jennifer Robinson, and Clyde Yancy.

Chair
Valentin Fuster MD, PhD
Director, Mount Sinai Heart
Director, Zena and Michael Wiener Cardiovascular Institute
and the Marie-Josée and Henry R Kravis Center of Cardiovascular Health
Richard Gorlin MD Heart Research Foundation Professor of Cardiology
at Mount Sinai Medical Center
New York, NY

Dr Fuster has no relevant financial relationships to disclose.

Panelists
Robert A Harrington, MD
Arthur L Bloomfield Professor of Medicine and Chair
Department of Medicine
Stanford University

Stanford, CA

Robert A Harrington, MD, has disclosed the following relevant financial relationships: Has served as an advisor or consultant for Bristol-Myers Squibb, Gilead, Johnson & Johnson, Merck, MyoKardia, Orexigen Therapeutics, Portola, Regado Biosciences, Sanofi, and WebMD.

He has received grants for clinical research from the American College of Cardiology, American Heart Association, National Heart, Lung, and Blood Institute, National Institute of Aging, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Merck, Novartis, Portola, Regado Biosciences, Sanofi, and the Medicines Company.



E Magnus Ohman, MD
Kent and Siri Rawson Director
Duke Program for Advanced Coronary Disease
Duke Heart Center
Senior Investigator
Duke Clinical Research Institute
Professor of Medicine
Duke University Medical Center

Durham, North Carolina

E Magnus Ohman, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: AstraZeneca Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Bristol-Myers Squibb; Gilead Sciences; LipoScience; Merck; POZEN; Roche; Sanofi; the Medicines Company; Johnson & Johnson Pharmaceutical Reseach & Development
Received grants for clinical research from: Daiichi Sankyo; Lilly



Clyde W Yancy MD, MSc
Magerstadt Professor of Medicine,
Northwestern University Feinberg School
of Medicine; Chief, Division of Cardiology,
Northwestern Memorial Hospital,

Chicago, Illinois

Clyde W Yancy, MD has no relevant financial relationships to disclose.


Jessica L Mega, MD, MPH
Assistant Professor, Harvard Medical School
Associate Physician, Brigham and Women's
Hospital, Boston, Massachusetts

Jessica L Mega, MD, has disclosed the following relevant financial relationships: Serves as a director, officer, partner, employee, advisor, consultant, or trustee for: Janssen Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; American Genomics

Received research grants: Bayer HealthCare Pharmaceuticals; Bristol-Myers Squibb; Daiichi Sankyo; Eli Lilly; Johnson & Johnson Pharmaceutical Research & Development.; Sanofi; Accumetrics; Nanosphere; National Institutes of Health/National Heart, Lung, and Blood Institute



Jennifer G Robinson, MD, MPH
Professor, Epidemiology and Medicine
University of Iowa; Professor, University
of Iowa Hospitals and Clinics, Iowa City

Iowa

Jennifer G Robinson, MD, has disclosed the following relevant financial relationships: Serves as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer, Sanofi; Regeneron Pharmaceuticals

Received research grants from: Amarin Corporation; Amgen; AstraZeneca Pharmaceuticals; Daiichi Sankyo; Esperion Therapeutics; Genetech/Hoffman La Roche, GlaxoSmithKline; Merck; Regeneron Pharmaceuticals; Sanofi; Zinfandel, Takeda Pharmaceuticals North America

Commenting is moderated. See our Terms of Use.
Post as: